Martin Balastik

Martin Balastik

Auto-generated profile, based on publicly available information

Martin Balastik

Department of Molecular Neurobiology, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2006 in Nature
Verified
Journal Article
Closed access
PDF file
LPLucia Pastorino
Lucia Pastorino
ASAnyang Sun
Anyang Sun
PLPei-Jung Lu
Pei-Jung Lu
XZXiao Zhen Zhou
Xiao Zhen Zhou
MBMartin Balastik
Martin Balastik
KLKun Ping Lu
Kun Ping Lu

12 November 2018 in The EMBO Journal
Verified
Journal Article
Closed access
PDF file
MMMaria M Magiera
Maria M Magiera
SBSatish Bodakuntla
Satish Bodakuntla
JŽJakub Žiak
Jakub Žiak
SLSabrina Lacomme
Sabrina Lacomme
PSPatricia Marques Sousa
Patricia Marques Sousa
CJCarsten Janke
Carsten Janke

1 June 2012 in Molecular Cell
Verified
Journal Article
Closed access
SMSang-Hyun Min
Sang-Hyun Min
ALAlan W. Lau
Alan W. Lau
TLTae Ho Lee
Tae Ho Lee
HIHiroyuki Inuzuka
Hiroyuki Inuzuka
SWShuo Wei
Shuo Wei
KLKun Ping Lu
Kun Ping Lu

19 August 2008 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
MBMartin Balastik
Martin Balastik
FFFrancesco Ferraguti
Francesco Ferraguti
APAndre Pires
Andre Pires
TLTae Ho Lee
Tae Ho Lee
GAGonzalo Alvarez-Bolado
Gonzalo Alvarez-Bolado
PGPeter Gruss
Peter Gruss
TRIM RING finger proteins have been shown to play an important role in cancerogenesis, in the pathogenesis of some human hereditary disorders, and in the defense against viral infection, but the function of the majority of TRIM proteins remains unknown. Here, we show that TRIM RING finger protein TRIM2, highly expressed in the nervous system, is an UbcH5a-dependent ubiquitin ligase. We further demonstrate that TRIM2 binds to neurofilament light subunit (NF-L) and regulates NF-L ubiquitination. Additionally, we show that mice deficient in TRIM2 have increased NF-L level in axons and NF-L-filled axonal swellings in cerebellum, retina, spinal cord, and cerebral cortex. The axonopathy is followed by progressive neurodegeneration accompanied by juvenile-onset tremor and ataxia. Our results demonstrate that TRIM2 is an ubiquitin ligase and point to a mechanism regulating NF-L metabolism through an ubiquitination pathway that, if deregulated, triggers neurodegeneration.

7 December 2008 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
TLTae Ho Lee
Tae Ho Lee
ATAdrian Tun-Kyi
Adrian Tun-Kyi
RSRong Shi
Rong Shi
JLJormay Lim
Jormay Lim
CSChristina Soohoo
Christina Soohoo
KLKun Ping Lu
Kun Ping Lu

1 April 2008 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
JLJormay Lim
Jormay Lim
MBMartin Balastik
Martin Balastik
TLTae Ho Lee
Tae Ho Lee
KNKazuhiro Nakamura
Kazuhiro Nakamura
YLYih-Cherng Liou
Yih-Cherng Liou
KLKun Ping Lu
Kun Ping Lu
Tau pathology is a hallmark of many neurodegenerative diseases including Alzheimer disease (AD) and frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17). Genetic tau mutations can cause FTDP-17, and mice overexpressing tau mutants such as P301L tau are used as AD models. However, since no tau mutations are found in AD, it remains unclear how appropriate tau mutant mice are as an AD model. The prolyl isomerase Pin1 binds and isomerizes tau and has been implicated in protecting against neurodegeneration, but whether such Pin1 regulation is affected by tau mutations is unknown. Consistent with earlier findings that Pin1 KO induces tauopathy, here we demonstrate that Pin1 knockdown or KO increased WT tau protein stability in vitro and in mice and that Pin1 overexpression suppressed the tauopathy phenotype in WT tau transgenic mice. Unexpectedly, Pin1 knockdown or KO decreased P301L tau protein stability and abolished its robust tauopathy phenotype in mice. In contrast, Pin1 overexpression exacerbated the tauopathy phenotype in P301L tau mice. Thus, Pin1 has opposite effects on the tauopathy phenotype depending on whether the tau is WT or a P301L mutant, indicating the need for disease-specific therapies for tauopathies.